Vbi vaccines inc/bc (VBIV)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16
Revenues

415

574

647

640

360

2,684

259

234

178

-

-

-

-

-

-

-

-

Revenues

-

-

-

-

-

-

-

-

-

-

193

344

127

137

281

82

48

Operating expenses:
Cost of revenues

2,577

2,394

1,977

2,354

1,179

1,228

801

1,067

1,413

1,227

1,334

1,357

1,275

1,090

1,501

703

377

Research and development

3,193

4,530

5,401

7,361

9,040

10,082

10,507

10,914

6,964

6,531

5,205

4,528

4,654

4,218

3,371

2,123

254

General and administration

4,058

-2,474

9,412

3,194

3,960

9,604

3,493

3,987

3,425

3,423

2,795

2,771

3,045

3,494

3,149

3,138

1,980

Total operating expenses

9,828

10,742

16,790

12,909

14,179

21,192

14,801

15,968

11,802

11,181

9,334

8,656

8,974

24,844

-8,021

5,964

2,611

Loss from operations

-9,413

-10,168

-16,143

-12,269

-13,819

-18,508

-14,542

-15,734

-11,624

-10,980

-9,141

-8,312

-8,847

-8,665

-7,740

-5,882

-2,563

Interest expense, net of interest income of $202 and $12 (including related party see Note 8)

-

-

-

-

-

-

-

-

-

-

-

-

704

-

-

-

-

Interest expense, net of interest income (including related party - see Note 8)

582

524

626

566

480

741

716

636

539

-

742

743

-

-

-62

3

25

Foreign exchange gain (loss)

1,637

-183

607

-335

-307

1

-112

-361

-88

131

81

42

482

-286

-503

-531

1,509

Loss before income taxes

-8,358

-10,875

-16,162

-13,170

-14,606

-19,248

-15,370

-16,731

-12,251

-11,542

-9,802

-9,013

-9,069

-10,191

-7,299

-6,416

-1,079

Income tax expense

-

-

-

-

-

-

-

-

-

0

0

0

-431

-1,780

0

0

0

NET LOSS

-8,358

-10,875

-16,162

-13,170

-14,606

-19,248

-15,370

-16,731

-12,251

-11,542

-9,802

-9,013

-8,638

-8,411

-7,299

-6,416

-1,079

Other comprehensive (loss) income - currency translation adjustments

-6,653

-

-

-

1,727

-

-

-

-

-

-

-

-

-

-

-

-

Foreign currency translation adjustments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-506

381

-

Other comprehensive (loss) income - currency translation adjustments

-

-

-1,165

1,746

-

-

1,541

-1,087

-1,902

-573

2,818

1,890

126

-

-

-

-691

COMPREHENSIVE LOSS

-15,011

-9,777

-17,327

-11,424

-12,879

-23,023

-13,829

-17,818

-14,153

-12,115

-6,984

-7,123

-8,512

-9,828

-7,805

-6,035

-1,770

Net loss per share of common shares, basic and diluted

-0.05

-0.03

-0.15

-0.13

-0.15

-0.28

-0.24

-0.26

-0.19

-0.20

-0.24

-0.22

-0.22

-0.28

-0.20

-0.23

-0.06

Weighted-average number of common shares outstanding, basic and diluted

178,289

176,883

105,742

97,678

97,481

69,770

64,383

64,257

64,179

56,289

40,229

40,089

40,026

37,489

36,150

27,618

18,914